LC-MS/MS exploration of biocomponents and hepatoprotective activity of Ageratum houstonianum Mill in a rat model of thioacetamide-induced liver fibrosis.

Authors

Abeer M El Sayed, Doaa El Hadidy, Neamat Zakaria, Mona El Tantawy, Taha El Alfy

Published in

Natural product research. Pages 1-10. Jul 17, 2026. Epub Jul 17, 2026.

Abstract

Liver fibrosis is a reversible pathological condition, whereas cirrhosis, the end-stage of liver fibrosis, is irreversible. Ageratum houstonianum Mill. is one of the important medicinal plants introduced to Egypt. DNA fingerprints were investigated to characterise the Egyptian plant. LC-MS/MS analysis was performed to elucidate the metabolite profile of A. houstonianum Mill. leaves. The data identified 39 and 49 metabolites including polyphenolics and lipids in negative and positive ion modes, respectively. The hepatoprotective activity of the leaves of A.houstonianum in a rat model of thioacetamide-induced liver fibrosis was performed. At the dose, 300 mg/kg of leaf extract showed significant protection from elevated total bilirubin levels 4.76%. A molecular docking study was performed to explore the potential mechanism underlying the observed hepatoprotective activity. As a result, it was suggested that A. houstonianum Mill. exerted a hepatoprotective effect comparable to silymarin and might directly improve the structural and functional integrities of the liver.

PMID:
42467883
Bibliographic data and abstract were imported from PubMed on 18 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.